+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

New Visiongain report says that the Global Electrosurgical Energy Devices Market Set To Grow To $4.9bn By 2023

30 July 2018
Pharma

Visiongain’ has launched a new pharma report Electrosurgical Energy Devices Market Report : Electrosurgical Generators, Instruments and Accessories, Argon and Smoke Management Systems, Bipolar Instruments, Monopolar Instruments, Patient Return Electrodes, Dispersive Electrodes, Cords, Cables and Adapters, General Surgery, Gynaecologic, Urologic, Orthopaedic, Cardiovascular, Cosmetic, Neurosurgery

The electrosurgical energy devices market is driven by factors such as increasing geriatric population, increasing demand for minimally invasive surgeries, and the launch of technologically advanced electrosurgical energy devices. However, pitfalls such as stringent government regulations are restraining the market for electrosurgical energy devices.
By product type, electrosurgical instruments and accessories dominated the market in 2017 owing to the high use of instruments and accessories in different surgical procedures such as cosmetic surgery, neurosurgery, cardiovascular surgery, urologic surgery, general surgery and others.

The lead analyst of the report commented “The growth of the electrosurgical device market is estimated to be catalysed by opportunities in untapped, emerging markets with high potential due to improving healthcare infrastructure, unmet healthcare needs, rise in chronic diseases and increased demands for minimally invasive surgeries.

The healthcare industry in emerging economies is developing at a significant rate due to augmentation in demand for better healthcare services, significant investments to improve healthcare infrastructure and growth of medical tourism industry in emerging countries.”

Leading companies featured in the report include B. Braun Melsungen AG, Bovie Medical Corporation, Conmed, ERBE Elektromedizin GmbH , Johnson & Johnson, KLS Martin Group, Medtronic, Megadyne Medical Products, Inc., Olympus Corporation, Utah Medical Products, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Antibiotics Market Report 2023-2033

The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.

31 January 2023

Read

Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033

The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.

31 January 2023

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033

The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.

31 January 2023

Read

Visiongain Publishes Human Microbiome Market Report 2023-2033

The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.

30 January 2023

Read